In 2020, Exxon Mobil’s (XOM) scientists told the company’s top executives that the algae biofuels program was falling short of its stated goals, but a week later, Exxon told investors that algae could become a more prolific source of biofuel, Collin Eaton of The Wall Street Journal reports, citing documents reviewed by the Journal. The scientists did not agree with how the data was presented to investors and some documents show executives knew the $500M algae research project wasn’t meeting its goals outside the lab, people familiar with the matter and documents show.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XOM:
- 3 Energy Stocks to Watch as Strait of Hormuz Crisis Lifts Oil Prices
- Sable Offshore Stock (SOC) Gains on Finally Starting Oil Sales — Is This a Turning Point?
- Wall Street Raises Earnings Estimates Despite War Fears as NVDA, AMD, and SPY Show Resilience
- AI Models Split on Exxon Mobil (XOM) as Cyclical Pressures Meet Strong Execution
- The Week That Was, The Week Ahead: Macro and Markets, Mar. 29
